Phil Ambery is a Global Clinical Leader within the Late Stage Cardiovascular Research Group in AstraZeneca. He has nearly 20 years of experience working in the cardiovascular and metabolism field in the pharmaceutical industry, and is also an Acute Medicine Physician, still seeing patients, with Cambridge University Hospitals Trust. He’s particularly interested in metabolism, insulin resistance and associated cardiovascular and renal disease, and in regards to COVID-19, how co-morbidities impact on outcomes. In his spare time he’s also a specialist partner with the General Medical Council in the UK, specialising in certification of academic Physicians, a dual fellow of the Royal College of Physicians and Faculty of Pharmaceutical Medicine, and lives just south of Gothenburg, where he can go walking in the forest with his wife, four children and two Schnauzer dogs.